159 related articles for article (PubMed ID: 32038622)
21. Interferon-γ-Producing CD4
Romano A; Brown N; Ashwin H; Doehl JSP; Hamp J; Osman M; Dey N; Rani GF; Ferreira TR; Kaye PM
Front Immunol; 2021; 12():700501. PubMed ID: 34557190
[TBL] [Abstract][Full Text] [Related]
22. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
23. Ly6C
Terrazas C; Varikuti S; Oghumu S; Steinkamp HM; Ardic N; Kimble J; Nakhasi H; Satoskar AR
Sci Rep; 2017 Oct; 7(1):14693. PubMed ID: 29089636
[TBL] [Abstract][Full Text] [Related]
24. The circulating immunoglobulins negatively impact on the parasite clearance in the liver of Leishmania donovani-infected mice via dampening ROS activity.
Srinontong P; Wu Z; Sato K; Nagaoka H; Maekawa Y
Biochem Biophys Res Commun; 2018 Nov; 506(1):20-26. PubMed ID: 30336975
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
[TBL] [Abstract][Full Text] [Related]
26. Differential Induction of SOCS Isoforms by
Chandrakar P; Parmar N; Descoteaux A; Kar S
J Immunol; 2020 Feb; 204(3):596-610. PubMed ID: 31882519
[TBL] [Abstract][Full Text] [Related]
27. IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasis.
Owens BM; Beattie L; Moore JW; Brown N; Mann JL; Dalton JE; Maroof A; Kaye PM
PLoS Pathog; 2012; 8(7):e1002827. PubMed ID: 22911108
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of Infection.
Varikuti S; Natarajan G; Volpedo G; Singh B; Hamza O; Messick GV; Guerau-de-Arellano M; Papenfuss TL; Oghumu S; Satoskar AR
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31182615
[TBL] [Abstract][Full Text] [Related]
29. In-situ proliferation contributes to the accumulation of myeloid cells in the spleen during progressive experimental visceral leishmaniasis.
Osorio EY; Medina-Colorado AA; Travi BL; Melby PC
PLoS One; 2020; 15(11):e0242337. PubMed ID: 33180876
[TBL] [Abstract][Full Text] [Related]
30. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
[TBL] [Abstract][Full Text] [Related]
31. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
32. Distinct Roles for CD4
Bunn PT; Montes de Oca M; de Labastida Rivera F; Kumar R; Ng SS; Edwards CL; Faleiro RJ; Sheel M; Amante FH; Frame TCM; Muller W; Haque A; Uzonna JE; Hill GR; Engwerda CR
J Immunol; 2018 Dec; 201(11):3362-3372. PubMed ID: 30355785
[TBL] [Abstract][Full Text] [Related]
33. Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar.
Ghosh M; Mandal L; Maitra S; Rakshit S; Paul K; Bagchi J; Ganguly D; Pal C; Bandyopadhyay S
J Infect Dis; 2006 Aug; 194(3):294-301. PubMed ID: 16826476
[TBL] [Abstract][Full Text] [Related]
34. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
[TBL] [Abstract][Full Text] [Related]
35. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
[TBL] [Abstract][Full Text] [Related]
36. Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.
Polley R; Sanos SL; Prickett S; Haque A; Kaye PM
Infect Immun; 2005 Dec; 73(12):7996-8001. PubMed ID: 16299292
[TBL] [Abstract][Full Text] [Related]
37. Tissue requirements for establishing long-term CD4+ T cell-mediated immunity following Leishmania donovani infection.
Bunn PT; Stanley AC; de Labastida Rivera F; Mulherin A; Sheel M; Alexander CE; Faleiro RJ; Amante FH; Montes De Oca M; Best SE; James KR; Kaye PM; Haque A; Engwerda CR
J Immunol; 2014 Apr; 192(8):3709-18. PubMed ID: 24634490
[TBL] [Abstract][Full Text] [Related]
38. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.
Melby PC; Yang YZ; Cheng J; Zhao W
Infect Immun; 1998 Jan; 66(1):18-27. PubMed ID: 9423834
[TBL] [Abstract][Full Text] [Related]
39. Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host.
Bandyopadhyay S; Bhattacharjee A; Banerjee S; Halder K; Das S; Paul Chowdhury B; Majumdar S
Infect Immun; 2015 Dec; 83(12):4476-86. PubMed ID: 26351281
[TBL] [Abstract][Full Text] [Related]
40. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
